PAPER
Acrylate Lynchpin Approach toward the Synthesis of Stolonidiol
2777
6-[(1S,3R,E)-2-(Bromomethylene)-3-(2-hydroxypropan-2-yl)-
1-methylcyclopentyl]-4-methylenehexanal (5)
stirred for 8 h. Sat. aq NaHCO3 soln (3 mL) was carefully added to
the reaction mixture. The resulting mixture was then extracted with
EtOAc (3 × 5 mL). The combined organic layers were washed with
brine (15 mL), dried (Na2SO4), and concentrated under reduced
pressure. The crude material was purified by silica gel chromatog-
raphy (hexanes–EtOAc, 4:1 to hexanes–EtOAc, 1:1) to provide the
diol as a pale yellow oil; yield: 29 mg (98%).
The diol (10 mg, 0.029 mmol, 1.0 equiv) was dissolved in CH2Cl2
(0.500 mL) and the flask was placed in a 0 °C bath. Solid NaHCO3
(7 mg, 0.087 mmol, 3.0 equiv) was then added. Dess–Martin peri-
odinane (14 mg, 0.032 mmol, 1.1 equiv) was added as a solid in a
single portion. After 30 min of stirring, excess periodinane was
quenched by addition of sat. aq Na2S2O3 soln (2 mL) followed by
10 min of vigorous stirring. The mixture was extracted with CH2Cl2
(2 × 5 mL) and the combined organic extracts were washed with
brine (15 mL), dried (Na2SO4), and concentrated under reduced
pressure. The crude material was purified by silica gel chromatog-
raphy (hexanes–EtOAc, 9:1 to hexanes–EtOAc, 4:1) to provide 5 as
a viscous, clear yellow oil; yield: 8.6 mg (60%).
Rf = 0.25 (hexanes–EtOAc, 1:1).
IR (neat): 3420, 1717, 1700, 1628, 1275, 1145 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.69 (dd, J = 15.0, 11.2 Hz, 1 H),
6.19 (d, J = 11.2 Hz, 1 H), 5.80 (d, J = 15.0 Hz, 1 H), 4.71 (s, 2 H),
3.72 (s, 3 H), 3.64 (t, J = 6.5 Hz, 2 H), 3.05 (t, J = 4.1 Hz, 1 H), 2.09–
1.96 (m, 3 H), 1.89–1.76 (m, 3 H), 1.71–1.64 (m, 4 H), 1.51–1.45
(m, 2 H), 1.29 (s, 3 H), 1.18 (s, 3 H), 1.16 (s, 3 H).
Rf = 0.69 (hexanes–EtOAc, 1:1).
IR (neat): 3433, 1721, 1643, 1266, 1094 cm–1.
13C NMR (100 MHz, CDCl3): δ = 168.0, 166.0, 149.6, 144.0, 122.8,
118.6, 109.0, 74.1, 62.7, 54.0, 51.4, 46.8, 42.9, 36.8, 32.4, 31.5,
30.6, 30.0, 28.4, 27.4, 26.7.
HRMS (ESI+): m/z [M + Na]+ calcd for C21H34O4Na: 373.2349;
found: 373.2349.
1H NMR (400 MHz, CDCl3): δ = 9.78 (t, J = 1.3 Hz, 1 H), 6.10 (d,
J = 1.3 Hz, 1 H), 4.78 (s, 1 H), 4.69 (s, 1 H), 2.91–2.89 (m, 1 H),
2.57 (dt, J = 7.5, 1.3 Hz, 2 H), 2.34 (t, J = 7.5 Hz, 2 H), 2.01–1.67
(m, 6 H), 1.56–1.52 (m, 2 H), 1.37 (s, 3 H), 1.27 (s, 3 H), 1.18 (s, 3
H).
13C NMR (100 MHz, CDCl3): δ = 202.0, 157.6, 147.9, 109.4, 102.3,
74.8, 55.6, 48.0, 42.9, 41.8, 38.1, 31.9, 30.3, 28.9, 28.2, 27.8, 27.1.
Methyl (2E,4E)-4-[(2S,5R)-5-(2-Hydroxypropan-2-yl)-2-meth-
yl-2-(3-methylene-6-oxohexyl)cyclopentylidene]but-2-enoate
(7)
HRMS (ESI+): m/z [M + Na + H]+ calcd for C17H27BrO2Na:
366.1128; found: 366.1121.
To a soln of the diol (15 mg, 0.043 mmol, 1.0 equiv) in CH2Cl2
(0.500 mL) at 23 °C was added solid NaHCO3 (14 mg, 0.171 mmol,
4.0 equiv) in a single portion. Solid Dess–Martin periodinane (20
mg, 0.047 mmol, 1.1 equiv) was added in small portions over 20
min. After 10 min, the reaction mixture was diluted with sat. aq
Na2S2O3 soln (5 mL) followed by 10 min of vigorous stirring. The
mixture was extracted with CH2Cl2 (3 × 5 mL) and the combined
organic extracts were washed with brine (15 mL), dried (Na2SO4),
and concentrated under reduced pressure. The crude material was
purified by silica gel chromatography (hexanes–EtOAc, 9:1 to hex-
anes–EtOAc, 4:1) to provide 7 as a viscous, clear yellow oil; yield:
12 mg (83%).
Methyl (2E,4E)-4-[(2S,5R)-2-{6-[(tert-Butyldimethylsilyl)oxy]-
3-methylenehexyl}-5-(2-hydroxypropan-2-yl)-2-methylcyclo-
pentylidene]but-2-enoate (22)
To a soln of vinyl bromide 21 (0.120 g, 0.263 mmol, 1.0 equiv) in
DMF (2.0 mL), Ph3P (14 mg, 0.052 mmol, 0.2 equiv), TBAB (84
mg, 0.263 mmol, 1.0 equiv), methyl acrylate (0.237 mL, 2.61 mmol,
10.0 equiv), and Et3N (0.294 mL, 2.08 mmol, 8.0 equiv) were add-
ed. The reaction mixture was sparged with argon and stirred for 20
min. Solid Pd(OAc)2 (12 mg, 0.052 mmol, 0.20 equiv) was added
and the reaction mixture was sparged with argon again; the flask
was placed in an oil bath heated to 100 °C for 16 h. The mixture was
cooled and diluted with H2O (10 mL), then extracted with EtOAc
(10 mL). The organic layer was washed with brine (4 × 15 mL),
dried (Na2SO4), and concentrated under reduced pressure. The
crude material was purified by silica gel chromatography (hexanes–
EtOAc, 20:1 to hexanes–EtOAc, 4:1) to provide 22 as a clear yellow
oil; yield: 74 mg (61%).
Rf = 0.38 (hexanes–EtOAc, 1:1).
IR (neat): 3489, 1717, 1629, 1604, 1274, 1143 cm–1.
1H NMR (400 MHz, CDCl3): δ = 9.76 (t, J = 1.7 Hz, 1 H), 7.69 (dd,
J = 15.0, 11.2 Hz, 1 H), 6.19 (dd, J = 11.2, 1.7 Hz, 1 H), 5.80 (d, J =
15.0 Hz, 1 H), 4.75 (s, 1 H), 4.67 (s, 1 H), 3.72 (s, 3 H), 3.06–3.04
(m, 1 H), 2.55 (dt, J = 7.5, 1.7 Hz, 2 H), 2.32 (t, J = 7.5 Hz, 2 H),
2.04–1.96 (m, 1 H), 1.89–1.83 (m, 1 H), 1.81–1.75 (m, 1 H), 1.70–
1.66 (m, 1 H), 1.52–1.48 (m, 4 H), 1.29 (s, 3 H), 1.19 (s, 3 H), 1.17
(s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 202.0, 167.9, 165.8, 147.9, 143.9,
122.8, 118.7, 109.4, 74.2, 54.0, 51.4, 46.7, 42.8, 41.8, 36.8, 31.9,
30.0, 28.4, 28.1, 27.3, 26.7.
Rf = 0.28 (hexanes–EtOAc, 4:1).
IR (neat): 3468, 1719, 1705, 1629, 1604, 1100, 835 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.69 (dd, J = 15.0, 11.2 Hz, 1 H),
6.19 (dd, J = 11.2, 1.4 Hz, 1 H), 5.79 (d, J = 15.0 Hz, 1 H), 4.68 (s,
2 H), 3.72 (s, 3 H), 3.59 (t, J = 6.5 Hz, 2 H), 3.06–3.03 (m, 1 H),
2.04–1.91 (m, 3 H), 1.84–1.76 (m, 3 H), 1.69–1.57 (m, 4 H), 1.51–
1.46 (m, 2 H), 1.29 (s, 3 H), 1.19 (s, 3 H), 1.16 (s, 3 H), 0.89 (s, 9
H), 0.04 (s, 6 H).
HRMS (CI+): m/z [M + H]+ calcd for C21H33O4: 349.2379; found:
349.2373.
13C NMR (100 MHz, CDCl3): δ = 168.0, 166.1, 149.8, 144.1, 122.9,
118.7, 108.7, 77.3, 74.2, 62.8, 54.1, 51.5, 46.9, 43.0, 36.8, 32.4,
31.7, 31.0, 30.1, 28.5, 27.4, 26.8, 26.0, 18.4, –5.1.
HRMS (ESI+): m/z [M + Na]+ calcd for C27H48O4SiNa: 487.3214;
found: 487.3214.
Acknowledgment
The authors are grateful for the financial support of the Robert A.
Welch Foundation (F-1694), the Texas Institute of Diagnostic and
Drug Development (H-F-0032), and The University of Texas at
Austin. T.B. acknowledges financial assistance from the Myasthe-
nia Gravis Foundation of America.
Methyl (2E,4E)-4-[(2S,5R)-2-(6-Hydroxy-3-methylenehexyl)-5-
(2-hydroxypropan-2-yl)-2-methylcyclopentylidene]but-2-eno-
ate
To a soln of TBS ether 22 (40 mg, 0.086 mmol, 1.0 equiv) in THF
(1.0 mL) at 23 °C was slowly added neat HF·py (70% HF; 0.039
mL, 0.430 mmol, 5.0 equiv) and the resulting cloudy solution was
Supporting Information for this article is available online at
m
tgioSrantnugIifoop
r
itmnatr
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2012, 44, 2770–2778